IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PIZZI, Marina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.539
EU - Europa 6.332
AS - Asia 1.928
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 16
SA - Sud America 11
AF - Africa 10
AN - Antartide 1
Totale 15.853
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.505
PL - Polonia 3.221
CN - Cina 1.217
UA - Ucraina 1.023
DE - Germania 603
IT - Italia 535
HK - Hong Kong 255
GB - Regno Unito 252
FI - Finlandia 246
IN - India 232
IE - Irlanda 173
FR - Francia 154
VN - Vietnam 126
RU - Federazione Russa 45
BE - Belgio 37
CA - Canada 32
SG - Singapore 30
SE - Svezia 26
TR - Turchia 23
EU - Europa 16
AU - Australia 14
IR - Iran 14
KR - Corea 14
NL - Olanda 8
CL - Cile 6
MU - Mauritius 6
BR - Brasile 4
JP - Giappone 4
RO - Romania 4
IL - Israele 3
ES - Italia 2
ET - Etiopia 2
ID - Indonesia 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
JM - Giamaica 1
KE - Kenya 1
MK - Macedonia 1
MX - Messico 1
OM - Oman 1
ZA - Sudafrica 1
Totale 15.853
Salva come PNG Salva come JPEG
Città #
Warsaw 3.221
Fairfield 1.040
Woodbridge 812
Jacksonville 732
Houston 601
Ashburn 531
Ann Arbor 491
Chandler 474
Cambridge 441
Seattle 394
Wilmington 383
Princeton 314
Nanjing 298
Brescia 252
Hong Kong 252
Dearborn 206
Beijing 205
Dublin 172
New York 162
Helsinki 131
Dong Ket 126
Nanchang 89
Pune 81
Shenyang 78
Des Moines 76
Hebei 71
Jinan 64
Lancaster 62
Tianjin 59
Changsha 56
San Diego 48
Milan 44
Shanghai 36
Brussels 35
London 30
Jiaxing 29
Kunming 29
Ningbo 28
Zhengzhou 23
Taizhou 22
Hangzhou 21
Lanzhou 21
Toronto 20
San Francisco 19
Verona 19
Orange 18
Guangzhou 17
Haikou 17
San Mateo 16
Phoenix 15
Augusta 13
Kocaeli 13
Norwalk 13
San Giuliano Milanese 13
Boardman 12
Kilburn 12
Leawood 11
Ardabil 10
Taiyuan 9
Mumbai 8
Nürnberg 8
Ottawa 8
Pavia 8
Melbourne 7
Chions 6
Los Angeles 6
Monmouth Junction 6
Oxford 6
Rome 6
Cattolica 5
Changchun 5
Falls Church 5
La Spezia 5
Napoli 5
San Donà Di Piave 5
Seoul 5
Singapore 5
Chicago 4
Corridonia 4
Hefei 4
New Bedfont 4
Paris 4
Alzano Lombardo 3
Bergamo 3
Berlin 3
Birmingham 3
Canberra 3
Central 3
Chiswick 3
Fulda 3
Gunzenhausen 3
Islington 3
Redwood City 3
Rho 3
San Cesareo 3
Sondrio 3
São Paulo 3
Timisoara 3
Ulsan 3
Walnut 3
Totale 12.670
Salva come PNG Salva come JPEG
Nome #
CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid 301
Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation 268
PEA and luteolin synergistically reduce mast cell-mediated toxicity and elicit neuroprotection in cell-based models of brain ischemia 263
Glutamatergic neurons induce expression of functional glutamatergic synapses in primary myotubes. 259
Glutamatergic Reinnervation and Assembly of Glutamatergic Synapses in Adult Rat Skeletal Muscle Occurs at Cholinergic Endplates 246
Glutamatergic reinnervation through peripheral nerve graft dictates assembly of glutamatergic synapses at rat skeletal muscle 245
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 244
1B/(-)IRE DMT1 Expression during Brain Ischemia Contributes to Cell Death Mediated by NF-κB/RelA Acetylation at Lys310 230
The End Is the Beginning: Parkinson's Disease in the Light of Brain Imaging 226
NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases 223
NF-κB and epigenetic mechanisms as integrative regulators of brain resilience to anoxic stress. 222
Priming of cultured neurons with sabeluzole results in long-lasting inhibition of neurotoxin-induced tau expression and cell death. 217
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 217
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. 214
Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke 214
Mild inflammatory profile without gliosis in the c-rel deficient mouse modeling a late-onset parkinsonism 211
Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window. 210
Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model 207
Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation 196
A Polyphenol-Enriched Supplement Exerts Potent Epigenetic-Protective Activity in a Cell-Based Model of Brain Ischemia 194
Pharmacological targeting of the beta-amyloid precursor protein intracellular domain 169
Mitochondria and alpha-synuclein: Friends or foes in the pathogenesis of Parkinson's disease? 168
NUOVO IMPIEGO TERAPEUTICO PREVENTIVO DELLA SUBUNITA' C-REL DELLA PROTEINA NF-KAPPAB E NUOVO IMPIEGO DI UN ANIMALE TRASGENICO NON UMANO CHE PORTA LA DELEZIONE DEL GENE C-REL (C-REL-/-) 160
The gamma-Secretase Modulator CHF5074 Reduces the Accumulation of Native Hyperphosphorylated Tau in a Transgenic Mouse Model of Alzheimer's Disease 152
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 150
Spinal cord mGlu1a receptors - Possible target for amyotrophic lateral sclerosis therapy 146
Targeting IKK2 by pharmacological inhibitor AS602868 prevents excitotoxic injury to neurons and oligodendrocytes. 146
Post-ischemic brain damage: NF-kappaB dimer heterogeneity as a molecular determinant of neuron vulnerability 142
NF-kappaB p50/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia. 142
The Role of Mast Cells in Stroke 140
Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia. 139
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 139
NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice 133
Chapter 24 NF-KappaB Dimers in the Regulation of Neuronal Survival 129
c-Rel deficient mice, a mouse model of "spreading" PD-like pathology. 128
A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release. 125
N-methyl-D-aspartate neurotoxicity in hippocampal slices: protection by aniracetam. 122
Cellular mechanisms for neurotensin receptor-mediated release of prolactin. 121
A Tau antisense oligonucleotide decreases neurone sensitivity to excitotoxic injury. 120
Activation of dopamine D2 receptors linked to voltage-sensitive potassium channels reduces forskolin-induced cyclic AMP formation in rat pituitary cells. 120
Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration. 117
Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line 116
Inhibition of glutamate-induced neurotoxicity by a tau antisense oligonucleotide in primary culture of rat cerebellar granule cells 111
Activation of multiple metabotropic glutamate receptor subtypes prevents NMDA-induced excitotoxicity in rat hippocampal slices. 110
Pharmacological basis for dopamine D-2 receptor diversity 109
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 107
The gamma-secretase modulator CHF5074 elicits neuroprotection and increases histone acetylation in primary cortical neurons exposed to oxygen glucose deprivation 105
Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. 105
Tolerance to hypoactivity and sensitization to hyperactivity after chronic treatment with a presynaptic dose of lisuride in rats 104
Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke. 104
Synapsin III alterations in Parkinson's disease 104
Electrophysiological and metabolic effects of CHF5074 in the hippocampus: protection against in vitro ischemia. 103
Mitochondrial Dysfunction and Alpha-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First? 103
SYNERGIC ROLE OF RESVERATROL AND HDACi MS-275 IN NEUROPROTECTION 101
The differential coupling mechanism of dopamine D-2 receptor subtypes: importance for the actions of neuroleptic drugs 101
Post-synaptic D1 and D2 dopamine receptors are present in rabbit renal and mesenteric arteries 100
Repeated administration of (−) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions 100
Various Ca2+ entry blockers prevent glutamate-induced neurotoxicity. 100
Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices 99
Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices. 99
Differential expression of fetal and mature tau isoforms in primary cultures of rat cerebellar granule cells during differentiation in vitro 99
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 99
Spinal cord mGlu1a receptors: possible target for amyotrophic lateral sclerosis therapy. 99
c-Rel deficient mice, a mouse model of “spreading” PD-like pathology 99
Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol. 98
EXACERBATED AGE-DEPENDENT LOSS OF NIGRAL DOPAMINERGIC NEURONS IN NF-KAPPAB C-REL -/- MICE 98
Properties of benzodiazepine binding sites in peripheral blood lymphocytes 97
Lack of vasoactive intestinal peptide-releasing property in prolactin cells from ovariectomized rats: contribution of post-transductional impairments 97
Cortical neurons induce the expression of glutamate receptors in primary myotubes 96
Opposing regulation of amyloid precursor protein by ionotropic and metabotropic glutamate receptors. 95
The inhibitor of IkappaBalpha phosphorylation BAY 11-7082 prevents NMDA neurotoxicity in mouse hippocampal slices. 95
Differential pattern of expression of G proteins in nucleus striatum from 6-hydroxydopamine lesioned rats. 95
Inhibition of IκBα phosphorylation prevents glutamate-induced NF-κB activation and neuronal cell death 95
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. 94
Degenerazione età –dipendente dei neuroni dopaminergici della sostanza nera nei topi NF-kappaB cRel 93
An in vitro method of diagnosing Parkinson's disease 92
Neuroprotection by metabotropic glutamate receptor agonists on kainate-induced degeneration of motor neurons in spinal cord slices from adult rat. 91
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 91
Differential expression of fetal and mature tau isoforms in primary cultures of rat cerebellar granule cells during differentiation in vitro. 90
Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells. 90
Peripheral and central mechanisms of action of serotoninergic anorectic drugs. 90
A bioinformatics analysis of memory consolidation reveals involvement of the transcription factor c-rel. 89
Glutamatergic innervation of rat skeletal muscle by supraspinal neurons: a new paradigm in spinal cord injury repair 88
Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation 88
Differential up-regulation of D-1 and D-2 dopamine receptor function in mesostriatal areas but not in cortical-limbic brain regions of rats chronically treated with (?)sulpiride and SCH 23390 88
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 85
Molecular mechanisms of glutamate-induced neurodegeneration 85
Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotection. 84
Acetylation of NF-kappaB p50/RelA and histones in the epigenetic regulation of pro-apoptotic transcription: a neuroprotective target in brain ischemia 84
Reversal of glutamate excitotoxicity by activation of PKC-associated metabotropic glutamate receptors in cerebellar granule cells relies on NR2C subunit expression 83
Possible new targets for GPCR modulation: allosteric interactions, plasma membrane domains, intercellular transfer and epigenetic mechanisms 81
The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury. 80
Evidence for the presence of D2 but not D1 dopamine receptors in rat hypothalamic perifornical area. 80
Targeting epigenetic regulation of NF-KappaB and histones in the therapy of post-ischemic brain injury 77
Parkinson's disease: from synaptic loss to connectome dysfunction 75
Leptin increases axonal growth cone size in developing mouse cortical neurons by convergent signals inactivating glycogen synthase kinase-3beta. 74
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionate and kainate differently affect neuronal cytoarchitecture of rat cerebellar granule cells 74
Dopamine D2 receptor stimulation decreases the inositol trisphosphate level of rat striatal slices 74
Leptin Is Induced in the Ischemic Cerebral Cortex and Exerts Neuroprotection Through NF-{kappa}B/c-Rel-Dependent Transcription. 72
Blockade of the tumor necrosis factor-related apoptosis inducing ligand death receptor DR5 prevents beta-amyloid neurotoxicity. 71
Totale 13.021
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.111
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.111
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019957 0 0 0 0 0 0 0 0 0 238 382 337
2019/20204.854 585 219 214 430 311 576 451 529 345 714 219 261
2020/20212.949 94 320 98 362 120 293 190 336 404 267 279 186
2021/20221.396 121 272 25 37 25 64 87 77 70 181 129 308
2022/20231.311 187 34 56 102 134 329 3 132 192 27 58 57
2023/20241.128 92 34 120 82 68 325 55 66 276 10 0 0
Totale 16.406